Kim M. Hirshfield, MD, PhD


Dr. Hirshfield Discusses Screening Patients for Genetic Mutations

March 30, 2015

Kim M. Hirshfield, MD, PhD, medical oncologist, Stacy Goldstein Breast Cancer Center, Rutgers Cancer Institute of New Jersey, discusses selecting individuals to screen for genetic mutations and the challenges of better selecting patients to screen.